Peter Joseph Pappas Research Grants
Forecasted
Peter Joseph Pappas Research Grants support researchers studying severe preeclampsia and related pregnancy disorders to eliminate preterm delivery as the primary intervention by 2050.
Funder: Preeclampsia Foundation
Due Dates (Anticipated): August 2027 (Letter of Intent) | September 2027 (Full application)
Funding Amounts: $50,000–$100,000 per two-year project; up to $200,000 total annually
Summary: Supports research to eliminate preterm delivery as an intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy.
Key Information: PIs must hold faculty appointments at accredited universities or bona fide research centers; trainees cannot apply as PIs.
Description
The Preeclampsia Foundation’s Peter Joseph Pappas Research Grants support research aimed at eliminating delivery of preterm babies as the primary intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy by 2050. Named for the infant son of Lauren and Clement Pappas, the program supports work on disease mechanisms, diagnosis, prediction, therapeutic interventions, and preconception or inter-conception health.
Proposals should address research gaps identified by the 2020 workshop jointly sponsored by the Foundation and the Society for Maternal-Fetal Medicine. Areas of interest include preeclampsia pathways and subtypes, predicting severe disease, and preventing or reversing placental and organ dysfunction. Preference is given to studies using or building upon Preeclampsia Registry data, or contributing new patient-specific data or biological materials to the Registry, although Registry participation is not mandatory.
